SEC Form 5 · accession 0001104659-19-006899
STEMLINE THERAPEUTICS INC · STML
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
David Gionco
Officer — Chief Accounting Officer
Period of report
Mar 21, 2018
Accepted (ET)
Feb 8, 2019 · 8:56 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001264587
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy) | $4.12 | Mar 21, 2018 | G | 72,131 | D | Feb 24, 2017 | Feb 24, 2026 | Common Stock | 72,131 | 0 | D |
Explanation of responses
- F1On March 21, 2018, 72,131 options to purchase shares of common stock were gifted into an irrevocable trust for the benefit of Mr. Gionco's minor children. Mr. Gionco is not a trustee of the trust and has no investment control over the securities held by the trust.